Fresenius Medical Care (NYSE:FMS) Shares Gap Down to $21.42

Shares of Fresenius Medical Care AG (NYSE:FMS) gapped down prior to trading on Tuesday . The stock had previously closed at $21.42, but opened at $19.87. Fresenius Medical Care shares last traded at $19.94, with a volume of 69,024 shares traded.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Fresenius Medical Care in a report on Saturday, May 4th. They set a “strong-buy” rating for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Fresenius Medical Care currently has an average rating of “Hold” and an average price target of $32.25.

Fresenius Medical Care Stock Performance

The firm has a market capitalization of $12.25 billion, a P/E ratio of 22.70, a PEG ratio of 1.16 and a beta of 0.95. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.07 and a current ratio of 1.42. The company has a 50-day simple moving average of $19.69 and a two-hundred day simple moving average of $19.66.

Fresenius Medical Care (NYSE:FMS) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.11. Fresenius Medical Care had a return on equity of 4.99% and a net margin of 2.56%. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.32 billion. As a group, equities analysts forecast that Fresenius Medical Care AG will post 1.49 EPS for the current year.

Fresenius Medical Care Cuts Dividend

The firm also recently disclosed an annual dividend, which will be paid on Monday, June 3rd. Investors of record on Monday, May 20th will be paid a dividend of $0.437 per share. This represents a yield of 2.35%. The ex-dividend date is Friday, May 17th. Fresenius Medical Care’s payout ratio is currently 46.74%.

Hedge Funds Weigh In On Fresenius Medical Care

Several large investors have recently made changes to their positions in the business. Pacer Advisors Inc. increased its position in Fresenius Medical Care by 14,252.1% during the 4th quarter. Pacer Advisors Inc. now owns 488,401 shares of the company’s stock valued at $10,173,000 after buying an additional 484,998 shares in the last quarter. Envestnet Asset Management Inc. grew its position in Fresenius Medical Care by 362.2% during the 3rd quarter. Envestnet Asset Management Inc. now owns 259,033 shares of the company’s stock valued at $5,580,000 after purchasing an additional 202,991 shares during the last quarter. Moran Wealth Management LLC purchased a new position in Fresenius Medical Care in the fourth quarter worth about $3,247,000. Guardian Capital Advisors LP lifted its stake in shares of Fresenius Medical Care by 16.7% in the fourth quarter. Guardian Capital Advisors LP now owns 123,715 shares of the company’s stock worth $2,556,000 after buying an additional 17,725 shares in the last quarter. Finally, Partnership Wealth Management LLC purchased a new stake in shares of Fresenius Medical Care during the fourth quarter valued at approximately $2,340,000. 8.25% of the stock is currently owned by hedge funds and other institutional investors.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.